Predict your next investment

HEALTHCARE | Drug Development
socium.co.jp

See what CB Insights has to offer

Stage

Seed | Alive

About SOCIUM

Provider of drug repositioning and biomarker identification services.

SOCIUM Headquarter Location

Nihonbashi Royal Plaza Building, 7F 17-1 Nihonbashi Kabuto-cho, Chuo-ku

Tokyo, 103-0026,

Japan

Latest SOCIUM News

Fidelis names Mathias as Director of Underwriting; Murfet takes on CRO role

Aug 5, 2021

Fidelis Insurance Holdings Limited, the specialty insurance and reinsurance firm launched by Richard Brindle, has appointed Charles Mathias as its first Group Director of Underwriting, supporting the Chief Executive Officers (CEOs) of insurance, reinsurance, and Socium. In this newly created role, Mathias takes on responsibility for ensuring that the firm’s underwriting data, systems, processes and […] The post Fidelis names Mathias as Director of Underwriting; Murfet takes on CRO role appeared first on ReinsuranceNe.ws.

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.